The prognostic value of tumor size in colon cancer remains controversial. This study aimed to reveal the correlation between tumor size and prognosis of colon cancer.
Methods
A total of 491 patients with colon cancer were included in this study. The correlation of tumor size with prognosis, mismatch repair status, and other clinicopathological characteristics as well as tumor microenvironment was analyzed.
Results
For stage IIA microsatellite stable (MSS) colon cancer, tumors sized <3.5 cm and ≥5 cm were associated with a poorer disease free survival (DFS) compared with tumors sized between 3.5 and 5 cm (P = .002). Small tumor size (HR = 5.098, P = .001) and large tumor size (HR = 2.749, P = .029) were found to be independent prognostic factors for stage IIA MSS colon cancer. Moreover, high expression of transgelin (TAGLN), a marker of cancer-associated fibroblasts (CAFs), was found to be an independent prognostic factor for poorer DFS (HR = 9.651, P = .009), which was also associated with smaller tumor size (P = .027).
Conclusion
Small (<3.5 cm) and large (≥5 cm) tumor sizes are associated with decreased DFS in stage IIA MSS colon cancer. Enrichment of TAGLN+ CAFs is associated with decreased DFS and small tumor size.
BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2018;68(6):394-424.
2.
SiegelRLMillerKDGoding SauerAFedewaSAButterlyLFAndersonJC, et al.Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145-164.
3.
GillSLoprinziCLSargentDJThomeSDAlbertsSRHallerDG, et al.Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?J Clin Oncol. 2004;22(10):1797-1806.
4.
Schmidt-KittlerORaggTDaskalakisAGranzowMAhrABlankensteinTJ, et al.From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci U S A. 2003;100(13):7737-7742.
5.
KornpratPPollheimerMJLindtnerRASchlemmerARehakPLangnerC. Value of tumor size as a prognostic variable in colorectal cancer: a critical reappraisal. Am J Clin Oncol. 2011;34(1):43-49.
6.
SahaSShaikMJohnstonGSahaSKBerbigliaLHicksM, et al.Tumor size predicts long-term survival in colon cancer: an analysis of the national cancer data base. Am J Surg. 2015;209(3):570-574.
7.
MuralidharVNippRDMamonHJPungliaRSHongTSFerroneC, et al.association between very small tumor size and decreased overall survival in node-positive pancreatic cancer. Ann Surg Oncol. 2018;25(13):4027-4034.
8.
WoJYChenKNevilleBALinNUPungliaRS. Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer. J Clin Oncol. 2011;29(19):2619-2627.
9.
HuangBFengYMoSBCaiSJHuangLY. Smaller tumor size is associated with poor survival in T4b colon cancer. World J Gastroenterol. 2016;22(29):6726-6735.
10.
DaiWMoSXiangWHanLLiQWangR, et al.The critical role of tumor size in predicting prognosis for t1 colon cancer. Oncol. 2019;25(3):244-251.
11.
HuangBFengYZhuLXuTHuangLCaiG. Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database. Int J Surg. 2016;33 Pt A:157-163.
12.
LeeSYKimCHKimYJKimHR. Macroscopic serosal invasion and small tumor size as independent prognostic factors in stage IIA colon cancer. Int J Colorectal Dis. 2018;33(8):1139-1142.
13.
MuralidharVNippRDRyanDPHongTSNguyenPLWoJY. association between very small tumor size and increased cancer-specific mortality in node-positive colon cancer. Dis Colon Rectum. 2016;59(3):187-193.
14.
SantulloFBiondiACananziFCMFicoVTirelliFRicciR, et al.Tumor size as a prognostic factor in patients with stage IIa colon cancer. Am J Surg. 2018;215(1):71-77.
15.
WangYZhuoCShiDZhengHXuYGuW, et al.Unfavorable effect of small tumor size on cause-specific survival in stage IIA colon cancer, a SEER-based study. Int J Colorectal Dis. 2015;30(1):131-137.
16.
HuangBChenCNiMXueXCaiGCaiS. The association between small tumor size and poor survival in T4 mucinous adenocarcinoma of colon without distant metastasis. J BUON. 2017;22(1):170-177.
17.
HuZLiZMaZCurtisC. Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. Nat Genet. 2020;52(7):701-708.
18.
HuZDingJMaZSunRSeoaneJAScott ShafferJ, et al.Quantitative evidence for early metastatic seeding in colorectal cancer. Nat Genet. 2019;51(7):1113-1122.
19.
KleinCA. Parallel progression of primary tumours and metastases. Nat Rev Cancer. 2009;9(4):302-312.
20.
HosseiniHObradovicMMSHoffmannMHarperKLSosaMSWerner-KleinM, et al.Early dissemination seeds metastasis in breast cancer. Nature. 2016;540(7634):552-558.
21.
PanHCuiJCaiKZhouY. Increased cancer-specific mortality of very small size in carcinoembryonic antigen-elevated rectal cancer. Ann Transl Med. 2019;7(18):447.
22.
RothADTejparSDelorenziMYanPFioccaRKlingbielD, et al.Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: Results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J Clin Oncol. 2010;28(3):466-474.
23.
KlingbielDSaridakiZRothADBosmanFTDelorenziMTejparS. Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial. Ann Oncol. 2015;26(1):126-132.
24.
SargentDJMarsoniSMongesGThibodeauSNLabiancaRHamiltonSR, et al.Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010;28(20):3219-3226.
25.
YuBChenXLiJQuYSuLPengY, et al.Stromal fibroblasts in the microenvironment of gastric carcinomas promote tumor metastasis via upregulating TAGLN expression. BMC Cell Biol. 2013;14:17.
26.
BalanescuPLadaruABalanescuEPompilianVGologanuDCaraiolaS, et al.Circulating reticulocalbin 1 and reticulocalbin 3 in systemic sclerosis patients: results of a case control study. Clin Lab. 2016;62(6):1109-1116.
27.
LeeHOHongYEtliogluHEChoYBPomellaVVan den BoschB, et al.Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat Genet. 2020;52(6):594-603.
28.
ZhouYBianSZhouXCuiYWangWWenL, et al.Single-cell multiomics sequencing reveals prevalent genomic alterations in tumor stromal cells of human colorectal cancer. Cancer Cell. 2020;38(6):818-828
29.
FoulkesWDReis-FilhoJSNarodSA. Tumor size and survival in breast cancer--a reappraisal. Nat Rev Clin Oncol. 2010;7(6):348-353.
30.
EttingerDSWoodDEAggarwalCAisnerDLAkerleyWBaumanJR, et al.nccn guidelines insights: Non-small cell lung cancer, version 1.2020. J Natl Compr Canc Netw. 2019;17(12):1464-1472.
31.
MohlerJLAntonarakisESArmstrongAJD'AmicoAVDavisBJDorffT, et al.prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(5):479-505.
32.
CrozierJEMcMillanDCMcArdleCSAngersonWJAndersonJHHorganPG, et al.Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer. J Gastroenterol Hepatol. 2007;22(12):2288-2291.
33.
MillerWOtaDGiaccoGGuineeVIrimuraTNicolsonG, et al.Absence of a relationship of size of primary colon carcinoma with metastasis and survival. Clin Exp Metastasis. 1985;3(3):189-196.
34.
Makohon-MooreAIacobuzio-DonahueCA. Pancreatic cancer biology and genetics from an evolutionary perspective. Nat Rev Cancer. 2016;16(9):553-565.
35.
HanahanDWeinbergRA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674.
36.
ChambersAFGroomACMacDonaldIC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2(8):563-572.
37.
GoutSHuotJ. Role of cancer microenvironment in metastasis: Focus on colon cancer. Cancer Microenviron. 2008;1(1):69-83.
38.
QuailDFJoyceJA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423-1437.
39.
WangBLiFGuoLLuSMaJMaY, et al.Loss of survival advantage for deficient mismatch repair in patients with advanced colorectal cancer may be caused by changes in prognostic value of CD8+T cell. World J Surg Oncol. 2020;18(1):196.
40.
KiarisHChatzistamouIKalofoutisCKoutseliniHPiperiCKalofoutisA. Tumour-stroma interactions in carcinogenesis: basic aspects and perspectives. Mol Cell Biochem. 2004;261(1-2):117-122.
41.
OrimoAGuptaPBSgroiDCArenzana-SeisdedosFDelaunayTNaeemR, et al.Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005;121(3):335-348.
42.
FukumuraDXavierRSugiuraTChenYParkECLuN, et al.Tumor induction of VEGF promoter activity in stromal cells. Cell. 1998;94(6):715-725.
43.
ThompsonOMoghrabyJSAyscoughKRWinderSJ. Depletion of the actin bundling protein SM22/transgelin increases actin dynamics and enhances the tumourigenic phenotypes of cells. BMC Cell Biol. 2012;13:1.
44.
LeeEKHanGYParkHWSongYJKimCW. Transgelin promotes migration and invasion of cancer stem cells. J Proteome Res. 2010;9(10):5108-5117.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
